The Biotechnology Algae Cultivation (Micro Algae) market is divided primarily by application, which determines revenue distribution and R&D focus. Food & beverage products—such as dietary supplements, functional drinks, and algae‑based protein—account for roughly 30 % of market value, driven by consumer demand for sustainable nutrition. Pharmaceutical and nutraceutical uses—including omega‑3 fatty acids, antioxidants, and therapeutic compounds—represent about 25 % and benefit from high margin pricing and regulatory approvals. Cosmetics and personal‑care formulations leverage the skin‑protective and anti‑aging properties of pigments like astaxanthin, contributing 15 % of sales. Biofuel and energy applications, centered on biodiesel and bio‑jet fuel production, hold a 20 % share, reflecting ongoing government incentives and carbon‑reduction targets. Finally, animal feed—particularly aquaculture and livestock nutrition—captures the remaining 10 %, supported by cost‑effective protein substitution. This application‑centric taxonomy underpins the overall market size, with each segment’s growth rate influencing total industry expansion. Investors monitor these slices closely, as capital allocation shifts toward applications with higher CAGR expectations, notably biofuel and nutraceuticals, while regulatory landscapes shape entry barriers across segments.